Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rizwan Haq

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Blood|August 1, 2002
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathwaysJenny M-Y Ho, Melody H-H Nguyen, Jamil K Dierov, et al.
Plos Genetics|May 10, 2012
YY1 regulates melanocyte development and function by cooperating with MITFJuying Li, Jun S Song, Robert J A Bell, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumabAnna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, et al.
Cancer Medicine|March 16, 2021
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockadeElizabeth I Buchbinder, Jason L Weirather, Michael Manos, et al.
Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Nature Communications|November 16, 2019
Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapiesJoan Montero, Cécile Gstalder, Daniel J Kim, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2021
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort StudyGirish S Naik, Elizabeth I Buchbinder, Justine V Cohen, et al.
The Journal of Investigative Dermatology|February 24, 2015
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF RegulationMartin Lauss, Rizwan Haq, Helena Cirenajwis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2024
Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 TargetingMarco Ventin, Giulia Cattaneo, Shahrzad Arya, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Blood|August 1, 2002
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathwaysJenny M-Y Ho, Melody H-H Nguyen, Jamil K Dierov, et al.
Plos Genetics|May 10, 2012
YY1 regulates melanocyte development and function by cooperating with MITFJuying Li, Jun S Song, Robert J A Bell, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumabAnna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, et al.
Cancer Medicine|March 16, 2021
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockadeElizabeth I Buchbinder, Jason L Weirather, Michael Manos, et al.
Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Nature Communications|November 16, 2019
Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapiesJoan Montero, Cécile Gstalder, Daniel J Kim, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2021
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort StudyGirish S Naik, Elizabeth I Buchbinder, Justine V Cohen, et al.
The Journal of Investigative Dermatology|February 24, 2015
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF RegulationMartin Lauss, Rizwan Haq, Helena Cirenajwis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2024
Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 TargetingMarco Ventin, Giulia Cattaneo, Shahrzad Arya, et al.
Pageof 7